Replies to post #802875 on NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

Exactly my point. Good to see someone here gets it. They’d have to have a few fantastic customer contracts come out of nowhere that suddenly happened just when LP left? Nothing ever ads up when LP is involved.

>>There is no way a CDMO sold for $10-$20 million, and then two years later sold for $875 million. That is not possible - not even in the NWBO sphere of incompetence.

[learningcurve2020]

$875,000,000 for what exactly? And what should that make Advent / Sawston’s current worth?

>>Cognate operates an 80,000 square-foot site in Memphis, originally built in 2017 for autologous cell therapy manufacturing but now produces various cell types for customers’ clinical projects. “Our largest phase of clinical grade production was an autologous product for phase III clinical trials, mostly manufactured in Memphis with products shipped to more than 80 clinical sites in four countries,” the company states.

https://www.bioprocessintl.com/deal-making/cognate-buys-cobra-to-boost-gene-therapy-cdmo-capabilities

[seekinganswers]

One thing you all have in common is that you all were dumb enough to buy NWBO shares. That is a fact! Cool Club. LOL
Another thing in common is that you all post with confidence that which you know nothing about.
Nobody said $10-$20 million. Toucan was a an owner, but not the only owner. Nobody but LP knows what her payout was.
Stop speculating, and stop talking about things you know nothing about. Just friendly advice.